檢索結果 - Elisabetta Bugianesi

Refine Results
  1. 1
    Review article: steatosis, the metabolic syndrome and cancer

    Review article: steatosis, the metabolic syndrome and cancer 由 Elisabetta Bugianesi

    出版 2005
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action?

    EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action? 由 Elisabetta Bugianesi

    出版 2016
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  3. 3
    Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome

    Nonalcoholic fatty liver disease: The hepatic trigger of the metabolic syndrome 由 Federico Salamone, Elisabetta Bugianesi

    出版 2010
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  4. 4
    Should we undertake surveillance for HCC in patients with NAFLD?

    Should we undertake surveillance for HCC in patients with NAFLD? 由 Ramy Younes, Elisabetta Bugianesi

    出版 2017
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    NASH in Lean Individuals

    NASH in Lean Individuals 由 Ramy Younes, Elisabetta Bugianesi

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    NAFLD/NASH

    NAFLD/NASH 由 Elisabetta Bugianesi, Salvatore Petta

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis

    Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis 由 Andrea Marengo, Chiara Rosso, Elisabetta Bugianesi

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Impact of <scp>PNPLA3 I148M</scp> on Clinical Outcomes in Patients With <scp>MASLD</scp>

    Impact of <scp>PNPLA3 I148M</scp> on Clinical Outcomes in Patients With <scp>MASLD</scp> 由 Salvatore Petta, Angelo Armandi, Elisabetta Bugianesi

    出版 2024
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?

    Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality? 由 Ester Vanni, Elisabetta Bugianesi, Giorgio Maria Saracco

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    Insulin resistance: A metabolic pathway to chronic liver disease

    Insulin resistance: A metabolic pathway to chronic liver disease 由 Elisabetta Bugianesi, Arthur J. McCullough, Giulio Marchesini

    出版 2005
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults

    Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults 由 Andrea Marengo, R. Ibrahim Kamal Jouness, Elisabetta Bugianesi

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  12. 12
    Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers

    Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers 由 Claudia Sanna, Chiara Rosso, M. Marietti, Elisabetta Bugianesi

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease

    Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease 由 Marta Guariglia, Francesca Saba, Chiara Rosso, Elisabetta Bugianesi

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?

    Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? 由 Luca Valenti, Elisabetta Bugianesi, Utpal B. Pajvani, Giovanni Targher

    出版 2016
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  15. 15
    Management of non-alcoholic fatty liver disease

    Management of non-alcoholic fatty liver disease 由 Maria Letizia Petroni, Lucia Brodosi, Elisabetta Bugianesi, Giulio Marchesini

    出版 2021
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  16. 16
    Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease

    Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease 由 Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Elisabetta Bugianesi

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  17. 17
    An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance

    An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance 由 Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Elisabetta Bugianesi

    出版 2024
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  18. 18
    Gender-dependent alterations in serum leptin in alcoholic cirrhosis

    Gender-dependent alterations in serum leptin in alcoholic cirrhosis 由 Arthur J. McCullough, Elisabetta Bugianesi, Giulio Marchesini, Satish C. Kalhan

    出版 1998
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Prognostic significance of diabetes in patients with cirrhosis

    Prognostic significance of diabetes in patients with cirrhosis 由 Giampaolo Bianchi, Giulio Marchesini, Marco Zoli, Elisabetta Bugianesi, Andrea Fabbri, E Pisi

    出版 1994
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention

    Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention 由 Manuel Romero‐Gómez, Shira Zelber‐Sagi, Franz Martı́n, Elisabetta Bugianesi, Bernat Soria

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: